- Home
- BOXL vs TOVX Comparison
BOXL vs TOVX Comparison
Compare BOXL & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOXL
- TOVX
- Stock Information
- Founded
- BOXL 1985
- TOVX 2001
- Country
- BOXL United States
- TOVX United States
- Employees
- BOXL N/A
- TOVX N/A
- Industry
- BOXL Telecommunications Equipment
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- BOXL Telecommunications
- TOVX Health Care
- Exchange
- BOXL Nasdaq
- TOVX Nasdaq
- Market Cap
- BOXL 3.9M
- TOVX 3.8M
- IPO Year
- BOXL 2017
- TOVX 2006
- Fundamental
- Price
- BOXL $1.77
- TOVX $0.43
- Analyst Decision
- BOXL Buy
- TOVX Hold
- Analyst Count
- BOXL 3
- TOVX 1
- Target Price
- BOXL $5.00
- TOVX N/A
- AVG Volume (30 Days)
- BOXL 17.0K
- TOVX 1.6M
- Earning Date
- BOXL 08-06-2025
- TOVX 08-12-2025
- Dividend Yield
- BOXL N/A
- TOVX N/A
- EPS Growth
- BOXL N/A
- TOVX N/A
- EPS
- BOXL N/A
- TOVX N/A
- Revenue
- BOXL $121,223,000.00
- TOVX N/A
- Revenue This Year
- BOXL N/A
- TOVX N/A
- Revenue Next Year
- BOXL N/A
- TOVX N/A
- P/E Ratio
- BOXL N/A
- TOVX N/A
- Revenue Growth
- BOXL N/A
- TOVX N/A
- 52 Week Low
- BOXL $1.06
- TOVX $0.40
- 52 Week High
- BOXL $10.65
- TOVX $7.37
- Technical
- Relative Strength Index (RSI)
- BOXL 50.35
- TOVX 33.63
- Support Level
- BOXL $1.60
- TOVX $0.43
- Resistance Level
- BOXL $1.80
- TOVX $0.46
- Average True Range (ATR)
- BOXL 0.14
- TOVX 0.04
- MACD
- BOXL -0.02
- TOVX 0.02
- Stochastic Oscillator
- BOXL 38.20
- TOVX 15.54
About BOXL Boxlight Corporation
Boxlight Corp is a technology company that develops, sells, and services interactive solutions predominantly for the education market but also for the corporate and government sectors. The company currently designs, produces, and distributes interactive technologies, including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras, and other peripherals for the education market and non-interactive solutions including flat panels, LED video walls, and digital signage. The company also distributes science, technology, engineering, and math (or STEM) products, including 3D printing and robotics solutions and a portable science lab.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.